Laurent Fischer
Chief Executive Officer at ADVERUM BIOTECHNOLOGIES, INC.
Net worth: 1 M $ as of 2024-03-30
Profile
Dr. Laurent Fischer, MD, is a President, Chief Executive Officer & Director at Adverum Biotechnologies, Inc., an Independent Director at Mirum Pharmaceuticals, Inc., a Chairman at CTI BioPharma Corp.
and an Independent Director at Lycia Therapeutics, Inc. He is on the Board of Directors at Adverum Biotechnologies, Inc., Mirum Pharmaceuticals, Inc., Lycia Therapeutics, Inc. and dpa Deutsche Presse-Agentur GmbH.
Dr. Fischer was previously employed as an Independent Director by Senti Sub I, Inc., a Senior Advisor by Frazier Management LLC, a Senior Vice President by Allergan Ltd.
(Ireland), a Chief Executive Officer by Tobira Therapeutics, Inc., a Chairman, President & Chief Executive Officer by Jennerex Biotherapeutics, Inc., a Chairman & Chief Executive Officer by Tobira Therapeutics, Inc. /Old/, a Vice Chairman by Ocera Therapeutics, Inc. /Old/, a Vice President-Corporate Development by MedVantx, Inc., a President & Chief Executive Officer by Auxeris Therapeutics, Inc., a President & Chief Operating Officer by Rxcentric, Inc., a Senior Vice President-Global Virology by DuPont Merck Pharmaceutical Co., a Senior Vice President-Global Virology by DuPont Pharmaceuticals Co., and a Medical Director-Virology Group by Hoffmann-La Roche, Inc. He also served on the board at Panacos Pharmaceuticals, Inc. and AIDS Healthcare Foundation.
He received his undergraduate degree from the University of Geneva and a doctorate degree from the University of Geneva.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-11 | 68,614 ( 0.33% ) | 970 202 $ | 2024-03-30 | |
| 2023-06-11 | 6,750 ( 0.01% ) | 169 560 $ | 2024-03-30 |
Laurent Fischer active positions
| Companies | Position | Start |
|---|---|---|
| CTI BIOPHARMA CORP. | Chairman | 2017-09-25 |
| MIRUM PHARMACEUTICALS, INC. | Director/Board Member | 2019-05-31 |
| ADVERUM BIOTECHNOLOGIES, INC. | Chief Executive Officer | 2020-06-14 |
Lycia Therapeutics, Inc.
 Lycia Therapeutics, Inc. BiotechnologyHealth Technology Lycia Therapeutics, Inc. is a biotechnology company, which engages in the developing technology that utilizes lysosome-targeting chimeras. It uses LYTACs platform to discover and provide therapeutics that degrade extracellular and membrane-bound proteins that drive a range of difficult-to treat diseases, including cancers and autoimmune conditions. The company was founded by Carolyn R. Bertozzi in 2019 and is headquartered in San Diego, CA. | Director/Board Member | - |
dpa Deutsche Presse-Agentur GmbH
 dpa Deutsche Presse-Agentur GmbH Internet Software/ServicesTechnology Services dpa Deutsche Presse-Agentur GmbH publishes on-line news. It develops and produces multimedia news products for the Web, mobile portal, and print applications, as well as engages in managing mobile services for media companies, providing cross media services for newspapers, international still graphics, and offers picture agency services. The company was founded in 1949 and is headquartered in Hamburg, Germany. | Director/Board Member | - |
FORM Life Ventures
 FORM Life Ventures Investment ManagersFinance FORM Life (FORM Life ventures) is venture capital firm founded in 2022 by Markus Okumus. FORM Life Ventures is headquartered in Luxembourg. | Consultant / Advisor | - |
Former positions of Laurent Fischer
| Companies | Position | End |
|---|---|---|
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Consultant / Advisor | 2022-05-31 |
| ALLERGAN PLC | Corporate Officer/Principal | 2020-05-31 |
| TOBIRA THERAPEUTICS INC | Chief Executive Officer | 2016-10-31 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Laurent Fischer
| University of Geneva | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| MIRUM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 18 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
AIDS Healthcare Foundation
 AIDS Healthcare Foundation Investment Trusts/Mutual FundsMiscellaneous AIDS Healthcare Foundation is a non-profit organization which engages in the provision of medicine and advocacy programs for HIV/AIDS. The firm offers HIV and STD testing, thrift store, dental clinic, and healthcare center services. The company was founded by Michael Weinstein in 1987 and is headquartered in Los Angeles, CA. | Miscellaneous |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Commercial Services |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
| Rxcentric, Inc. | Technology Services |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
Auxeris Therapeutics, Inc.
 Auxeris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Auxeris Therapeutics, Inc. manufactures drugs for osteoporosis, bone metastasis and other bone diseases. The company was founded in 2002 and is located in St. Louis, MO | Health Technology |
dpa Deutsche Presse-Agentur GmbH
dpa Deutsche Presse-Agentur GmbH Internet Software/ServicesTechnology Services dpa Deutsche Presse-Agentur GmbH publishes on-line news. It develops and produces multimedia news products for the Web, mobile portal, and print applications, as well as engages in managing mobile services for media companies, providing cross media services for newspapers, international still graphics, and offers picture agency services. The company was founded in 1949 and is headquartered in Hamburg, Germany. | Technology Services |
Vytal, Inc.
 Vytal, Inc. Drugstore ChainsRetail Trade Vytal, Inc. provides medication access, adherence, and direct-to-patient consumer programs. It offers prescription assistance, patient engagement, anticipatory logistic solutions, and omni-channel platform. The company was founded Levin Scott Bechtler, Paul Cattaneo, and Robert J. Feeney Jr. in 2000 and is headquartered in San Diego, CA. | Retail Trade |
Ocera Therapeutics, Inc. /Old/
 Ocera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. is a San Diego based, privately held biopharmaceutical company founded in January 2005 by Dr. Eckard Weber and Dr. Laurent Fischer. Ocera focuses on the development of novel therapeutics in the areas of liver and gastrointestinal diseases. | Health Technology |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on October 6, 2006 and is headquartered in Madison, NJ. | Health Technology |
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
Lycia Therapeutics, Inc.
Lycia Therapeutics, Inc. BiotechnologyHealth Technology Lycia Therapeutics, Inc. is a biotechnology company, which engages in the developing technology that utilizes lysosome-targeting chimeras. It uses LYTACs platform to discover and provide therapeutics that degrade extracellular and membrane-bound proteins that drive a range of difficult-to treat diseases, including cancers and autoimmune conditions. The company was founded by Carolyn R. Bertozzi in 2019 and is headquartered in San Diego, CA. | Health Technology |
FORM Life Ventures
FORM Life Ventures Investment ManagersFinance FORM Life (FORM Life ventures) is venture capital firm founded in 2022 by Markus Okumus. FORM Life Ventures is headquartered in Luxembourg. | Finance |
- Stock Market
- Insiders
- Laurent Fischer
